razoxane has been researched along with Cardiac Remodeling, Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M | 1 |
| Asselin, BL; Athale, UH; Clavell, LA; Colan, SD; Dahlberg, SE; Henkel, JM; Laverdière, C; Lipshultz, SE; Lipsitz, SR; Michon, B; Miller, TL; Neuberg, DS; Rifai, N; Sallan, SE; Schorin, MA; Scully, RE; Silverman, LB | 1 |
| Calvé, A; Chalifour, LE; Noiles, W; Sebag, IA | 1 |
1 trial(s) available for razoxane and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
Topics: Antibiotics, Antineoplastic; Biomarkers; C-Reactive Protein; Cardiomyopathies; Cardiotonic Agents; Child; Child, Preschool; Doxorubicin; Echocardiography; Female; Heart; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Troponin T; Ventricular Function, Left; Ventricular Remodeling | 2012 |
2 other study(ies) available for razoxane and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling | 2010 |
The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum.
Topics: Animals; Antineoplastic Agents; Calcium-Binding Proteins; Calsequestrin; Cardiotonic Agents; Cardiotoxins; Doxorubicin; Female; Heart Ventricles; Infertility, Female; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Razoxane; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling; Weaning | 2012 |